November marked a pivotal month for Scivita Medical, where its accumulated innovative strength translated into rapid, strategic advancements on the global stage. The company achieved intensive breakthroughs across global markets and academia, demonstrating its comprehensive leadership in the endoscopy field through multi-dimensional innovations.
Overseas, Scivita Medical secured victories on two fronts: its Single-use Ureteroscope successfully gained market approval in Costa Rica, signifying a crucial step in its Latin American market strategy. Concurrently, its comprehensive Urology Single-use Solution made a significant entry into the UAE, aligning with the "Belt and Road" initiative and aiming to establish a benchmark brand in the premium Middle Eastern market.
Academically, Scivita Medical’s product portfolio garnered widespread recognition from international experts and channel partners through appearances on European and Middle Eastern stages—from a workshop in Sweden to premier international exhibitions in Oman, Germany, and Italy.
Domestically, the company continued its deep cultivation. Its rigid endoscope system solution was featured at a major gynecological conference in Hunan, and it persistently drove academic exchange with the "Urology Scivita Medical Journey" event in Suining. This created a synergistic momentum of parallel domestic and international market progress, driven by both academic and commercial wheels.
1. Entering Latin America, Making Strides in the Middle East: Scivita Medical's Single-use Endoscopes Secure Dual Breakthroughs
In November, Scivita Medical's Single-use Ureteroscope received market approval in Costa Rica. This ureteroscope, compatible with Scivita Medical's already marketed Full HD Endoscopic Image Processor (S300A), utilizes HD imaging to accurately capture subtle pathologies like urinary stones and tumors, providing clear diagnostic evidence. Its single-use design eliminates cross-infection risks, simplifies pre-operative procedures, and removes the burden of reprocessing reusable instruments. Its flexible operability adapts to complex scenarios like stricture exploration and stone management, making procedures more efficient and smooth.
This product can synergize with the company's previously launched Single-use Ureteroscope/Cystoscope and Single-use Hysteroscope in the region, forming a matrix of single-use endoscopic solutions covering key departments like Urology and Gynecology.
Following the "Belt and Road" strategy, Scivita Medical recently made a major push into the UAE's high-end medical market. The company's complete Urology Single-use Endoscopy Solution has been launched in the UAE. This product matrix covers innovative devices and consumables, including the Single-use Ureteroscope, Endoscopic Image Processor (S300A), Single-use Biopsy Forceps, Single-use Stone Extraction Basket, and Single-use Sterile Urological Guidewire, providing comprehensive technical support for local minimally invasive urological procedures.
The UAE, as a hub for medical innovation in the Middle East, has a growing demand for high-quality, high-safety medical devices. Scivita Medical's comprehensive solution directly addresses clinical pain points: the single-use design fundamentally prevents cross-infection, while HD imaging and flexible instrument channels assist physicians in performing complex operations like lithotripsy, stone extraction, and biopsy with precision.
2. Global Showcases, Technology Leadership: Scivita Medical Medical's Intensive Overseas Activities in Europe & the Middle East
November was a period of concentrated visibility for Scivita Medical overseas, with participation in several key European and Middle Eastern industry events. Through serialized, localized professional academic promotions, the company significantly enhanced the recognition and influence of its single-use endoscopes on the international stage.
On November 6, partnering with a renowned Swedish medical device service provider, Scivita Medical successfully hosted a single-use urology solution workshop themed "Breaking Stones, Breaking Limits" in Sweden. The event attracted numerous urology experts from Sweden, Norway, Denmark, and other Nordic countries. Combining theory and hands-on sessions, the workshop highlighted the technical advantages of the single-use flexible ureteroscope in stone treatment. Experts gained deep, practical experience with the product's exceptional performance in channel stability, image clarity, and operational ease. Many noted that this clinically-focused workshop format provided an excellent opportunity to evaluate new technology, laying a solid professional foundation for Scivita Medical's entry into the Nordic market.
From November 13-16, at the Arab Association of Urology (AAU) Conference 2025 in Oman, Scivita Medical presented its complete single-use urology portfolio, including single-use ureteroscopes, cystoscopes, and supporting consumables. The 6.0Fr Ultra-slim Ureteroscope, a highlight product making its Middle East debut, quickly became a focal point. Maintaining a 3.6Fr working channel while reducing the outer diameter to 6.0Fr ensures instrument passage while significantly minimizing patient urethral trauma. Many physicians, after hands-on experience, commented that its passage through narrow lumens and image quality met international advanced standards. This successful showcase opened new avenues for Scivita Medical in the premium Middle Eastern market.
.jpg)
.jpg)
From November 17-20, at MEDICA 2025, the world's largest medical trade fair in Düsseldorf, Germany, Scivita Medical comprehensively displayed its full range of rigid and flexible endoscopy system solutions. These included the 4K Fluorescence Imaging System, single-use endoscopes, and supporting consumables. Scivita Medical's booth attracted distributors and clinicians from Germany, France, the UK, and other European countries, who showed strong interest. The complete solutions for Gynecology and Urology, in particular, drew a steady stream of professional visitors for in-depth consultations and product trials. Many distributors indicated that Scivita Medical's product line completeness and technological advantages give it strong competitiveness in the European market.
3. Fluorescence-Guided Precision, Empowering Day Surgery: Scivita Medical's Rigid Endoscope System Featured at Hunan Academic Event
From November 7-8, 2025, the Annual Conference of the Gynecologic Day Surgery Committee of the Hunan Female Doctor Association & Seminar on New Advances in Gynecologic Day Surgery was successfully held at the Hunan Provincial Maternal and Child Health Care Hospital. Gathering numerous gynecology experts and scholars, the conference facilitated in-depth exchanges on the standardized management of day surgery and new technology applications. Scivita Medical was invited to exhibit and comprehensively demonstrated its 4K Endoscopic Fluorescence Camera System. This system features white light, fluorescence, and monochrome imaging functions, allowing simultaneous on-screen display of three modes with smooth, natural switching, aiding surgeons in precise observation and operation, effectively reducing surgical trauma, and improving patient outcomes.
During the event, the Scivita Medical team, through live demonstrations and detailed explanations, showcased the technical advantages of the 4K fluorescence laparoscope to attending experts. The product attracted attention from Director Ma Yunyun of Hunan Provincial Maternal and Child Health Care Hospital, as well as experts from Liuyang People's Hospital, Zhuzhou 331 Hospital, Huarong County People's Hospital, and other institutions, leading to extensive discussions about its clinical application. Scivita Medical further solidified its influence in the field of gynecologic minimally invasive surgery through this conference, laying a solid foundation for expanding its presence in the Central China market.
4．Urology Scivita Medical Journey | Precision Empowerment: Advancing Minimally Invasive Urology through Academic Ecosystem
On November 15, 2025, the "Urology Scivita Medical Journey - Suining Station" academic conference on new advances in urinary disease diagnosis and treatment, hosted by Suining Central Hospital and organized by Scivita Medical, was successfully held at the Suining Marriott Hotel. Aiming to promote the exchange and adoption of minimally invasive urological techniques, the event attracted numerous urology experts from Sichuan Province. Focusing on the themes "Unlocking Endoscopic Classics" and "Discussing Stone Management," experts like Professor Cui Shu and Professor Wei Wuran from Suining Central Hospital delved into hot topics such as post-prostatectomy incontinence management, FANS technique in RIRS, and new advances in PCNL puncture techniques.
Scivita Medical showcased innovative products like the Single-use Cystoscope and Single-use Ureteroscope (7.5Fr Ultra-slim), offering clinicians richer options for minimally invasive surgery. This academic meeting established a valuable communication platform for urologists in Eastern Sichuan, promoting the adoption of advanced diagnostic and therapeutic technologies in key hospitals through a combination of theoretical and practical discussions. As the organizer, Scivita Medical remains committed to supporting academic exchange in urology and driving the development and popularization of minimally invasive technologies.
The series of achievements in November clearly outlines Scivita Medical's strategic path, powered by innovation and played out on a global stage. By tightly integrating "Product Market Access" with "Academic Promotion," the company has not only successfully introduced China-innovated minimally invasive solutions to the world but also continuously gathered clinical insights through deep engagement, feeding back into product iteration and innovation. Looking ahead, Scivita Medical will continue to deepen its global footprint. Through close collaboration with medical partners worldwide, it aims to bring safer, more efficient, and more accessible minimally invasive technologies to more markets, truly realizing its vision of "Leading the Future of Minimally Invasive Surgery.